Evolocumab Benefits Accrue With Longer Follow-upFOURIER OLE

Factor XIa Inhibitor Encouraging in Phase 2 MI, Stroke Studies

No Benefit of Routine Stress Test POST-PCI in High-Risk Patients

Artificial Intelligence Poised to Change CV Risk Prevention

Albuminuria Linked to Higher CVD Risk in Diabetes

COVID-19 Vaccine Safe in Patients With Heart Failure

Rivaroxaban Outmatched by VKAs for AF in Rheumatic Heart Disease

AXIOMATIC-SSP: Cautious Optimism on Factor XI Inhibitor in Stroke

ALL-HEART: No Benefit of Allopurinol in Ischemic Heart Disease

Artificial Intelligence Beats Sonographers for Echo Accuracy

Dapagliflozin's HFpEF Benefit Recasts HF Treatment: DELIVER

DANCAVAS Hints at Benefit from Comprehensive CV Screening

PCI Fails to Beat OMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Vintage Drug Atop Loop Diuretics Boosts ADHF Decongestion: ADVOR

An Hour of Walking Per Week May Boost Longevity in Elderly

Sacubitril/Valsartan Shows Cognitive Safety in Heart Failure

Cannabis for Pain Linked to Slight Risk for Arrhythmia

Secondary CV Prevention Benefit From Polypill Shown

TIME: CV Events Similar With Evening or Morning Dose of BP Meds

NSAIDs Linked to Heart Failure Risk in Diabetes

Barcelona Beckons for First Hybrid ESC Congress



Mandrola Previews His Top 5 Trials from ESC 2022